Skip to main content
OpenTrials

Clinical trial condition

Night Blindness, Congenital Stationary, Autosomal Dominant 1

Explore clinical trials studying Night Blindness, Congenital Stationary, Autosomal Dominant 1. Study availability and eligibility vary by location and protocol.

5 public trials 1 recruiting study
Refine in advanced search Browse all conditions

Night Blindness, Congenital Stationary, Autosomal Dominant 1 trial results

Completed

A Safety Study for Cethrin (BA-210) in the Treatment of Acute Thoracic and Cervical Spinal Cord Injuries

NCT00500812

Conditions
Central Nervous System Diseases, Nervous System Diseases, Neurologic Manifestations, +11 more
Locations
  • St. Joseph's Hospital & Medical Center Phoenix, Arizona, United States
  • University of Cincinnati Mayfield Clinic and Spine Institute Cincinnati, Ohio, United States
  • Thomas Jefferson University Hospital Philadelphia, Pennsylvania, United States
  • Univ.of Virginia Health System Charlottesville, Virginia, United States
View Trial Details
Active, Not Recruiting

Study to Assess the Safety and Efficacy of OCU400 for Retinitis Pigmentosa and Leber Congenital Amaurosis

NCT05203939

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Enhanced S-Cone Syndrome, Eye Diseases, +9 more
Locations
  • Associated Retina Consultants Phoenix, Arizona, United States
  • Ocugen Site 5 - University of California, San Diego (UCSD) - Shiley Eye Institute La Jolla, California, United States
  • Ocugen Site 3 - Bascom Palmer Eye Institute Miami, Florida, United States
  • Ocugen Site 6 - Emory University Atlanta, Georgia, United States
View Trial Details
Active, Not Recruiting

A Study to Evaluate the Safety and Tolerability of QR-1123 in Subjects With Autosomal Dominant Retinitis Pigmentosa Due to the P23H Mutation in the RHO Gene

NCT04123626

Conditions
Autosomal Dominant Retinitis Pigmentosa, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, +17 more
Locations
  • Sue Anschutz-Rogers Eye Center, University of Colorado - Dept. of Ophthalmology Aurora, Colorado, United States
  • VitreoRetinal Associates Gainesville, Florida, United States
  • Shriners UK Ophthalmology - University of Kentucky Lexington, Kentucky, United States
  • Casey Eye Institute, OHSU Portland, Oregon, United States
View Trial Details

Related conditions